X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
0.611
+0.004 (0.66%)
At close: Dec 20, 2024, 4:00 PM
0.640
+0.029 (4.69%)
After-hours: Dec 20, 2024, 4:50 PM EST
X4 Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for X4 Pharmaceuticals stock have an average target of 3.50, with a low estimate of 1.50 and a high estimate of 5.00. The average target predicts an increase of 472.55% from the current stock price of 0.61.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 14, 2024.
Analyst Ratings
The average analyst rating for XFOR stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $1.5 | Strong Buy | Maintains | $5 → $1.5 | +145.38% | Nov 14, 2024 |
| Stifel | Stifel | Strong Buy Maintains $5 → $4 | Strong Buy | Maintains | $5 → $4 | +554.34% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +717.93% | Jun 28, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $5 | Buy | Reiterates | $5 | +717.93% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $5 | Strong Buy | Maintains | $3 → $5 | +717.93% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
3.44M
Revenue Next Year
19.86M
from 3.44M
Increased by 476.54%
EPS This Year
-0.24
from -0.57
EPS Next Year
-0.54
from -0.24
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 9.2M | 37.2M | 136.2M | |||
| Avg | 3.4M | 19.9M | 64.5M | |||
| Low | 1.9M | 9.1M | 22.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 981.3% | 585.9% | |||
| Avg | - | 476.5% | 224.9% | |||
| Low | - | 165.4% | 10.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.15 | -0.30 | -0.25 | |||
| Avg | -0.24 | -0.54 | -0.33 | |||
| Low | -0.68 | -0.76 | -0.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.